Correction for: TMX family genes and their association with prognosis, immune infiltration, and chemotherapy in human pan-cancer
Na Luo, Zhiqiang Mei, Qiqi Zhang, Hong Tang, Runlan Wan, Anni Deng, Xiaopan Zou, Chaoxiang Lv
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Immunotherapy and Biomarkers · Ferroptosis and cancer prognosis
This article has been corrected: The authors recently found that they inadvertently used adjusted instead of the original images for the “Vimentin” western blots shown in Figure 12I and 12J: Western blot analysis of EMT marker expression in TMX2-overexpressing HepG2 and Huh-7 cells (I), and Western blot analysis of EMT marker expression in TMX2-deficient HepG2 and Huh-7 cells (J). The authors provided original uncropped images of all western blots and corrected the mistake with the original “Vimentin” images. These corrections have no impact on the main conclusion. The authors apologize for any confusion or inconvenience caused by this error.
The corrected version of Figure 12 is provided below.